Skip to main content

Table 4 Treatments for HCC recurrence

From: C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion

  Recurrence  
Treatments on recurrence HCC with PV invasion (n=67) HCC without PV invasion (n=410) P value
Liver resection 0 (0%) 18 (4.4%) 0.091
Liver transplantation 3 (4.5%) 7 (1.7%) 0.154
RFA 6 (9.0%) 125 (30.5%) <0.001
TACE 39 (58.2%) 242 (59.0%) 0.894
Sorafenib 12 (17.9%) 67 (16.3%) 0.725
Radiation 9 (13.4%) 42 (10.2%) 0.400
Chemotherapy 5 (7.5%) 23 (5.6%) 0.573
  1. RFA, Radiofrequency ablation; TACE, Transarterial chemoembolization.